Complement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United States

International Archives of Allergy and Immunology

Volumn 146, Issue 3, 2008, Pages 255-261

  Shoemaker, Ritchie C ^a   Giclas, Patricia C ^b   Crowder, Chris ^c   House, Dennis ^a   Glovsky, M Michael ^d,e  

^a Center for Research on Biotoxin Associated Illnesses   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^e NONE   (United States)

Author keywords

Arthropod borne disease; Borrelia afzelii; Borrelia burgdorferi; Borrelia garinii

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A;

ADULT; AGED; ARTICLE; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; LYME DISEASE; MALE; PRIORITY JOURNAL; RASH; TICK BITE; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANIMALS; BORRELIA BURGDORFERI; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C4A; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS; INSECT BITES AND STINGS; LYME DISEASE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 45149108827     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116362     Document Type: Article

References (28)

1. Steere AC, Coburn J, Glickstein L: The emergence of Lyme disease. J Clin Invest 2004;113:1093-1109.
2. Barbour AG, Hayes SF: Biology of Borrelia species. Microbiol Rev 1986;50:381-400.
3. Centers for Disease Control and Prevention (CDC): Lyme disease - United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2004;53:365-369.
4. Steere AC: Lyme disease. N Engl J Med 2001;345:115-125.
5. Tibbles CD, Edlow JA: Does this patient have erythema migrans? JAMA 2007;297:2617-2627.
6. Engstrom SM, Shoop E, Johnson R: Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-427.
7. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP: Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005;18:484-509.
8. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J: Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990;335:312-315.
9. Artsob H, Huibner S: Complement fixation test for the diagnosis of Lyme disease. J Clin Microbiol 1990;28:637-638.
10. Brunner M, Sigal LH: Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. J Clin Microbiol 2001;39:3213-3221.
11. Schutzer SE, Coyle PK, Reid P, Holland B: Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 1999;282:1942-1946.
12. Zhong W, Oshmann P, Wellensiek HJ: Detection and preliminary characterization of circulating immunocomplexes in patients with Lyme disease. Med Microbiol Immunol 1997;186:153-158.
13. Nadelman RB, Nowakowski J, Fish D, Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Aguero-Rosenfeld ME, Dennis DT, Wormser GP, Tick Bite Study Group: Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.
14. Aronowitz R: Prevention of Lyme disease after tick bites. N Engl J Med 1993;328:136-139.
15. Salazar JC, Pope CD, Sellati TJ, Feder HM Jr, Kiely TG, Dardick KR, Buckman RL, Moore MW, Caimano MJ, Pope JG, Krause PJ, Radolf JD, Lyme Disease Network: Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol 2003;171:2660-2670.
16. Kochi S, Johnson R, Dalmasso A: Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi: role of antibody in formation of an effective membrane attack complex. J Immunol 1991;146:3964-3970.
17. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ: Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002;168:99-107.
18. Kuo M, Lane R, Giclas P: A comparative study of mammalian and reptilian alternative pathway of complement-mediated killing of the Lyme disease spirochete (Borrelia burgdorferi). J Parasitol 2000;86:1223-1228.
19. Kraiczy P, Sherka C Kirschfink M, Zipfel P, Brade V: Immune evasion of Borrelia burgdorferi: insufficient killing of pathogens by complement and antibody. Int J Med Microbiol 2002;33:141-146.
20. Kraiczy P, Skerka C, Kirschfink M, Zipfel P, Brade V: Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol 2001;1:393-401.
21. Kraiczy P, Hartmann K, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel PF, Wallich R, Stevenson B: Immunological characterization of the complement regulator factor H-binding CRASP and ERP proteins of Borrelia burgdorferi. Int J Med Microbiol 2004;293:152-157.
22. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E: Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immunol 2004;72:5759-5767.
23. Crother TR, Champion CI, Whitelegge JP, Aguilera R, Wu XY, Blanco DR, Miller JN, Lovett MA: Temporal analysis of antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect Immunol 2004;72:5063-5072.
24. Barbour A: Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984;57:521-525.
25. Bunikis J, Barbour A: Laboratory testing for suspected Lyme disease. Med Clin North Am 2002;86:311-340.
26. Glovsky M, Ward P, Johnson K: Complement determinations in human disease. Ann Allergy Asthma Immunol 2004;93:513-525, 605.
27. Gloor B, Stahel P, Muller C, Schmidt O, Buchler M, Uhl W: Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis. Scand J Gastroenterol 2003;38:1078-1082.
28. Fitzgerald T: Activation of the classical and alternative pathways of complement by Treponema pallidum and Treponema vincentii. Infect Immun 1987;55:2066-2073.